Accurate calculation of blood volume to be processed by apheresis to achieve target CD34⁺ cell numbers for PBPC transplantation

By Trickett A E   Smith S   Kwan Y L  

Cytotherapy, Vol. 3, Iss. 1, 2001-01 ,pp. : 5-10

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The CD34⁺ Cell Concentration in Peripheral Blood Predicts CD34⁺ Cell Yield in the Leukapheresis Product

By Hollingsworth KL   Zimmerman TM   Karrison T   Oliver A   Williams SF  

Cytotherapy, Vol. 1, Iss. 2, 1999-01 ,pp. : 141-146

Ashgate Publishing Ltd

Access to resources Recommend Favorite

CD34⁺ cell enrichment depletes atypical CD30⁺ cells from PBPC grafts in patients with HD

By Blystad AK   Torlakovic E   Holte H   Kvaløy S   Lenschow E   Kvalheim G  

Cytotherapy, Vol. 3, Iss. 4, 2001-07 ,pp. : 295-305

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products

By Braakman E.   Schuurhuis Gj   Preijers Fwmb   Voermans C.   Theunissen K.   van Riet I.   Fibbe We   Slaper-Cortenbach I.  

Cytotherapy, Vol. 10, Iss. 1, 2007-12 ,pp. : 83-89

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma

By Akkök Çiğğdem Akalin   Hervig Tor   Stamnesfet Siren   Nesthus Ingerid   Melve Guro K.   Lassalle Philippe   Bruserud Øystein  

Cytotherapy, Vol. 13, Iss. 10, 2011-11 ,pp. : 1259-1268

Ashgate Publishing Ltd

Access to resources Recommend Favorite